Notes in Gastric carcinoma

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	GI \| Gastric \| 1.1 \| Anatomy
Published	02/18/2024	GI \| Gastric \| 1.2 \| Epidemiology
Published	02/18/2024	GI \| Gastric \| 1.3.1 \| Aetiology and risk factors
Published	02/18/2024	GI \| Gastric \| 1.4 \| Biologic behaviour
Published	02/18/2024	GI \| Gastric \| 1.6 \| Clinical presentation
Published	02/18/2024	GI \| Gastric \| 2.1 \| Workup
Published	02/18/2024	GI \| Gastric \| 2.2 \| Staging
Published	02/18/2024	GI \| Gastric \| 2.3 \| Prognostic factors
Published	02/18/2024	GI \| Gastric \| 1.5.1 \| Pathologic classification
Published	02/18/2024	GI \| Gastric \| 1.3.2 \| Aetiology \| Hereditary diffuse gastric carcinoma
Published	02/18/2024	GI \| Gastric \| 1.3.3 \| Aetiology \| H Pylori
Published	02/18/2024	GI \| Gastric \| 1.3.4 \| Pathogenesis
Published	02/18/2024	GI \| Gastric \| 1.5.2 \| Macroscopic and microsocpic appearance
Published	02/18/2024	GI \| Gastric \| 3.2 \| Management \| Surgery
Published	02/18/2024	GI \| Gastric \| 3.3 \| Management \| Early stage gastric cancer (T1N0)
Published	02/18/2024	GI \| Gastric \| 3.4 \| Management \| T2-4 and/or LN+, resectable
Published	02/18/2024	GI \| Gastric \| 3.6 \| Stage IV disease
Published	02/18/2024	GI \| Gastric \| 3.7 \| Effect of treatment
Published	02/18/2024	GI \| Gastric \| 3.8 \| Screening and prevention
Published	02/18/2024	GI \| Gastric \| 3.9 \| Toxicity of chemotherapy
Published	02/18/2024	GI \| Gastric \| 4.1 \| RT technique \| Neoadjuvant RT - old
Published	02/18/2024	GI \| Gastric \| 4.2 \| RT technique \| Definitive
Published	02/18/2024	GI \| Gastric \| 4.3 \| RT technique \| Adjuvant RT
Published	02/18/2024	GI \| Gastric \| 2.4 \| Prognosis
Published	02/18/2024	GI \| Gastric \| 3.5 \| Initially unresectable non-metastatic disease
Published	02/18/2024	GI \| Gastric \| 3.1 \| Management \| Overview
Published	02/18/2024	GI \| Gastric \| 4.4 \| TOPGEAR trial and RT technique (Neoadjuvant ChemoRT)
Status	Last Update	Fields